BDBM118868 US9682940, 156

SMILES COc1ccccc1S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1

InChI Key InChIKey=MHHCTANFEIHAJZ-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 118868   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM118868(US9682940, 156)
Affinity DataEC50: >1.00E+4nMAssay Description:CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM118868(US9682940, 156)
Affinity DataEC50:  1nMAssay Description:CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...More data for this Ligand-Target Pair
In DepthDetails US Patent